<DOC>
	<DOCNO>NCT00485225</DOCNO>
	<brief_summary>Two stage study look different titration schedule patient moderate severe non-malignant chronic pain . Up 80 patient approximately 15 center US enrol . Study participation approximately 3 month .</brief_summary>
	<brief_title>Open Label , Safety Study EN3270 Patients With Moderate Severe Non-malignant , Chronic Pain</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>Opioid experience Hx ( min 3 month ) moderate severe pain nonmalignant well control current pain therapy On stable dose opioid medication great equal 14 day Have adequate personal support system include cohabitant Are able willing follow verbal write instruction provide write informed consent Are pregnant lactate Have pain secondary confirm suspect neoplasm Have history physical examination find incompatible safe participation study Have history alcohol drug abuse Have history physical examination find clinically significant skin abnormality would preclude use transdermal patch ( e.g. , psoriasis ) Have history currently manifest clinically significant psychiatric disorder Have know history allergy negatively impact respiratory function clinically significant level Plan MRI study Have clinically significant condition would , opinion investigator , preclude safe study participation Are schedule surgery require general anesthesia within study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>